Claire Bombardier - Publications

Affiliations: 
Health Policy, Management and Evaluation University of Toronto, Toronto, ON, Canada 
Area:
Epidemiology, Health Care Management

176 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cui K, Movahedi M, Bombardier C, Kuriya B. Cardiovascular risk factors are negatively associated with rheumatoid arthritis disease outcomes. Therapeutic Advances in Musculoskeletal Disease. 13: 1759720X20981217. PMID 33643444 DOI: 10.1177/1759720X20981217  0.32
2020 Tatangelo MR, Tomlinson G, Keystone E, Paterson JM, Bansback N, Bombardier C. Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal Study. Acr Open Rheumatology. PMID 33104286 DOI: 10.1002/acr2.11182  0.32
2020 Pope JE, Rampakakis E, Movahedi M, Cesta A, Sampalis JS, Bombardier C. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI). Rheumatology (Oxford, England). PMID 32789456 DOI: 10.1093/rheumatology/keaa343  0.32
2020 Fullerton LM, Brooks S, Sweezie R, Ahluwalia V, Bombardier C, Gagliardi AR. Patient, Rheumatologist and Therapist Perspectives on the Implementation of an Allied Health Rheumatology Triage (AHRT) Initiative in Ontario Rheumatology Clinics. Pragmatic and Observational Research. 11: 1-12. PMID 32095089 DOI: 10.2147/POR.S213966  0.4
2020 Hazlewood GS, Pokharel G, Deardon R, Marshall DA, Bombardier C, Tomlinson G, Ma C, Seow CH, Panaccione R, Kaplan GG. Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment. Plos One. 15: e0227635. PMID 31945089 DOI: 10.1371/journal.pone.0227635  0.32
2019 Tatangelo M, Tomlinson G, Paterson JM, Ahluwalia V, Kopp A, Gomes T, Bansback N, Bombardier C. Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage. Jama Network Open. 2: e1917053. PMID 31808927 DOI: 10.1001/jamanetworkopen.2019.17053  0.4
2019 Ahluwalia V, Brooks S, Sweezie R, Bell M, Kendzerska T, Widdifield J, Bombardier C. The Effect of Triage Assessments on Identifying Inflammatory Arthritis and Reducing Rheumatology Wait Times in Ontario. The Journal of Rheumatology. PMID 31154411 DOI: 10.3899/jrheum.180734  0.4
2019 Lau AN, Thorne JC, Movahedi M, Rampakakis E, Cesta A, Li X, Couto S, Sampalis J, Bombardier C. Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. The Journal of Rheumatology. PMID 30988121 DOI: 10.3899/jrheum.180486  0.32
2018 Pope JE, Movahedi M, Rampakakis E, Cesta A, Sampalis JS, Keystone E, Thorne C, Bombardier C. ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). Rmd Open. 4: e000738. PMID 30487995 DOI: 10.1136/rmdopen-2018-000738  0.32
2018 Kuriya B, Joshi R, Movahedi M, Rampakakis E, Sampalis JS, Bombardier C. High Disease Activity Is Associated with Self-reported Depression and Predicts Persistent Depression in Early Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative. The Journal of Rheumatology. PMID 29764967 DOI: 10.3899/jrheum.171195  0.32
2017 Pope JE, Rampakakis E, Movahedi M, Cesta A, Li X, Couto S, Sampalis JS, Bombardier C. Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI). Clinical and Experimental Rheumatology. PMID 29148403  0.32
2017 Hazlewood GS, Bombardier C, Tomlinson G, Marshall D. A Bayesian model that jointly considers comparative effectiveness research and patients' preferences may help inform GRADE recommendations: An application to rheumatoid arthritis treatment recommendations. Journal of Clinical Epidemiology. PMID 29051108 DOI: 10.1016/j.jclinepi.2017.10.003  0.32
2017 Barber CEH, Mosher DP, Ahluwalia V, Zummer M, Marshall DA, Choquette D, Lacaille D, Bombardier C, Lyddiatt A, Chandran V, Khodyakov D, Dao E, Barnabe C. Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis. The Journal of Rheumatology. PMID 28966205 DOI: 10.3899/jrheum.170421  0.4
2017 Ahluwalia V, Rampakakis E, Movahedi M, Cesta A, Li X, Sampalis JS, Bombardier C. Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative. Clinical Rheumatology. PMID 28879413 DOI: 10.1007/s10067-017-3805-4  0.4
2016 Widdifield J, Ivers NM, Bernatsky S, Jaakkimainen RL, Bombardier C, Thorne JC, Ahluwalia V, Paterson JM, Young J, Wing L, Tu K. Primary Care Screening and Management of Comorbidity in Rheumatoid Arthritis in Ontario, Canada. Arthritis Care & Research. PMID 27998044 DOI: 10.1002/acr.23178  0.4
2016 Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe DJ, Bombardier C. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis. The Cochrane Database of Systematic Reviews. 8: CD010227. PMID 27571502 DOI: 10.1002/14651858.CD010227.pub2  1
2016 Hazlewood GS, Bombardier C, Tomlinson G, Thorne C, Bykerk VP, Thompson A, Tin D, Marshall DA. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment. Rheumatology (Oxford, England). PMID 27477807 DOI: 10.1093/rheumatology/kew280  0.32
2016 Widdifield J, Bernatsky S, Thorne JC, Bombardier C, Jaakkimainen RL, Wing L, Paterson JM, Ivers N, Butt D, Lyddiatt A, Hofstetter C, Ahluwalia V, Tu K. Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data. Cmaj Open. 4: E205-12. PMID 27398365 DOI: 10.9778/cmajo.20150116  0.4
2016 Kviatkovsky MJ, Ramiro S, Landewé R, Dougados M, Tubach F, Bellamy N, Hochberg M, Ravaud P, Martin-Mola E, Awada H, Bombardier C, Felson D, Hajjaj-Hassouni N, Logeart I, Matucci-Cerinic M, et al. The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis. The Journal of Rheumatology. PMID 27307522 DOI: 10.3899/jrheum.151244  1
2016 Widdifield J, Tu K, Thorne JC, Bombardier C, Paterson JM, Jaakkimainen RL, Wing L, Butt DA, Ivers N, Hofstetter C, Lyddiatt A, Ahluwalia V, Bernatsky S. Patterns of care among first-time referrals to rheumatologists: Characteristics and timeliness of consultations and treatment in Ontario, Canada. Arthritis Care & Research. PMID 27110847 DOI: 10.1002/acr.22910  0.4
2016 Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. Bmj (Clinical Research Ed.). 353: i1777. PMID 27102806  0.32
2016 Widdifield J, Moura CS, Wang Y, Abrahamowicz M, Paterson JM, Huang A, Beauchamp ME, Boire G, Fortin PR, Bessette L, Bombardier C, Hanly JG, Feldman D, Bernatsky S. The Longterm Effect of Early Intensive Treatment of Seniors with Rheumatoid Arthritis: A Comparison of 2 Population-based Cohort Studies on Time to Joint Replacement Surgery. The Journal of Rheumatology. PMID 26879353 DOI: 10.3899/jrheum.151156  1
2016 Barber CE, Marshall DA, Mosher DP, Akhavan P, Tucker L, Houghton K, Batthish M, Levy DM, Schmeling H, Ellsworth J, Tibollo H, Grant S, Khodyakov D, Lacaille D. Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada. The Journal of Rheumatology. PMID 26773106 DOI: 10.3899/jrheum.150839  0.4
2016 Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: Abridged cochrane Systematic review and network meta-analysis Bmj (Online). 353. DOI: 10.1136/bmj.i1777  1
2016 Lin CA, Bhandari M, Guyatt G, Walter SD, Schemitsch EH, Swiontkowski M, Sanders D, Tornetta P, Sanders DW, Sprague S, Heels-Ansdell D, Buckingham L, Leece P, Viveiros H, Mignott T, ... ... Bombardier C, et al. Does Participation in a Randomized Clinical Trial Change Outcomes? An Evaluation of Patients Not Enrolled in the SPRINT Trial Journal of Orthopaedic Trauma. 30: 156-161. DOI: 10.1097/BOT.0000000000000533  1
2015 Widdifield J, Bernatsky S, Bombardier C, Paterson M. Rheumatoid Arthritis Surveillance in Ontario: Monitoring the Burden, Quality of Care and Patient Outcomes through Linkage of Administrative Health Data. Healthcare Quarterly (Toronto, Ont.). 18: 7-10. PMID 26718246  0.4
2015 Gagnier JJ, Oltean H, van Tulder MW, Berman BM, Bombardier C, Robbins CB. Herbal Medicine for Low Back Pain-A Cochrane Review. Spine. PMID 26630428 DOI: 10.1097/BRS.0000000000001310  1
2015 Beaton DE, Dyer S, Boonen A, Verstappen SM, Escorpizo R, Lacaille DV, Bosworth A, Gignac MA, Leong A, Purcaru O, Leggett S, Hofstetter C, Peterson IF, Tang K, Fautrel B, ... Bombardier C, et al. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research. The Journal of Rheumatology. PMID 26329339 DOI: 10.3899/jrheum.141077  0.88
2015 Ruban TN, Jacob B, Pope JE, Keystone EC, Bombardier C, Kuriya B. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative. Clinical Rheumatology. PMID 26245721 DOI: 10.1007/s10067-015-3031-x  1
2015 Moura CS, Abrahamowicz M, Beauchamp ME, Lacaille D, Wang Y, Boire G, Fortin PR, Bessette L, Bombardier C, Widdifield J, Hanly JG, Feldman D, Maksymowych W, Peschken C, Barnabe C, et al. Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study. Arthritis Research & Therapy. 17: 197. PMID 26235697 DOI: 10.1186/s13075-015-0713-3  0.4
2015 Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax. 70: 677-82. PMID 25911222 DOI: 10.1136/thoraxjnl-2014-206470  1
2015 Widdifield J, Bernatsky S, Paterson JM, Tomlinson G, Tu K, Kuriya B, Thorne JC, Pope JE, Hollands S, Bombardier C. Trends in excess mortality among patients with rheumatoid arthritis in ontario, Canada. Arthritis Care & Research. PMID 25623141 DOI: 10.1002/acr.22553  1
2015 Bellamy N, Hochberg M, Tubach F, Martin-Mola E, Awada H, Bombardier C, Hajjaj-Hassouni N, Logeart I, Matucci-Cerinic M, van de Laar M, van der Heijde D, Dougados M. Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis. Arthritis Care & Research. 67: 972-80. PMID 25581339 DOI: 10.1002/acr.22538  1
2015 Moura CS, Abrahamowicz M, Beauchamp ME, Lacaille D, Wang Y, Boire G, Fortin PR, Bessette L, Bombardier C, Widdifield J, Hanly JG, Feldman D, Maksymowych W, Peschken C, Barnabe C, et al. Early medication use in new-onset rheumatoid arthritis may delay joint replacement: Results of a large population-based study Arthritis Research and Therapy. 17. DOI: 10.1186/s13075-015-0713-3  1
2014 Oltean H, Robbins C, van Tulder MW, Berman BM, Bombardier C, Gagnier JJ. Herbal medicine for low-back pain. The Cochrane Database of Systematic Reviews. 12: CD004504. PMID 25536022 DOI: 10.1002/14651858.CD004504.pub4  1
2014 Kydd AS, Seth R, Buchbinder R, Edwards CJ, Bombardier C. Uricosuric medications for chronic gout. The Cochrane Database of Systematic Reviews. 11: CD010457. PMID 25392987 DOI: 10.1002/14651858.CD010457.pub2  1
2014 Sriranganathan MK, Vinik O, Bombardier C, Edwards CJ. Interventions for tophi in gout. The Cochrane Database of Systematic Reviews. 10: CD010069. PMID 25330136 DOI: 10.1002/14651858.CD010069.pub2  1
2014 Seth R, Kydd AS, Buchbinder R, Bombardier C, Edwards CJ. Allopurinol for chronic gout. The Cochrane Database of Systematic Reviews. 10: CD006077. PMID 25314636 DOI: 10.1002/14651858.CD006077.pub3  1
2014 Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C. Description of active joint count trajectories in juvenile idiopathic arthritis. The Journal of Rheumatology. 41: 2466-73. PMID 25274882 DOI: 10.3899/jrheum.130835  1
2014 Hazlewood GS, Akhavan P, Schieir O, Marshall D, Tomlinson G, Bykerk V, Bombardier C. Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II. Journal of Clinical Epidemiology. 67: 1274-85. PMID 25240769 DOI: 10.1016/j.jclinepi.2014.07.005  1
2014 Vinik O, Wechalekar MD, Falzon L, Buchbinder R, van der Heijde DM, Bombardier C. Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review. The Journal of Rheumatology. Supplement. 92: 70-4. PMID 25180131 DOI: 10.3899/jrheum.140465  1
2014 Sriranganathan MK, Vinik O, Falzon L, Bombardier C, van der Heijde DM, Edwards CJ. Interventions for tophi in gout: a Cochrane systematic literature review. The Journal of Rheumatology. Supplement. 92: 63-9. PMID 25180130 DOI: 10.3899/jrheum.140464  1
2014 Seth R, Kydd AS, Falzon L, Bombardier C, van der Heijde DM, Edwards CJ. Preventing attacks of acute gout when introducing urate-lowering therapy: a systematic literature review. The Journal of Rheumatology. Supplement. 92: 42-7. PMID 25180127 DOI: 10.3899/jrheum.140461  1
2014 Kydd AS, Seth R, Buchbinder R, Falzon L, Edwards CJ, van der Heijde DM, Bombardier C. Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews. The Journal of Rheumatology. Supplement. 92: 33-41. PMID 25180126 DOI: 10.3899/jrheum.140460  1
2014 Wechalekar MD, Vinik O, Moi JH, Sivera F, van Echteld IA, van Durme C, Falzon L, Bombardier C, Carmona L, Aletaha D, Landewé RB, van der Heijde DM, Buchbinder R. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors. The Journal of Rheumatology. Supplement. 92: 15-25. PMID 25180124 DOI: 10.3899/jrheum.140458  1
2014 Widdifield J, Bombardier C, Bernatsky S, Paterson JM, Green D, Young J, Ivers N, Butt DA, Jaakkimainen RL, Thorne JC, Tu K. An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance. Bmc Musculoskeletal Disorders. 15: 216. PMID 24956925 DOI: 10.1186/1471-2474-15-216  1
2014 Widdifield J, Paterson JM, Bernatsky S, Tu K, Tomlinson G, Kuriya B, Thorne JC, Bombardier C. The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis & Rheumatology (Hoboken, N.J.). 66: 786-93. PMID 24757131 DOI: 10.1002/art.38306  1
2014 Shea B, Swinden MV, Ghogomu ET, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. The Journal of Rheumatology. 41: 1049-60. PMID 24737913 DOI: 10.3899/jrheum.130738  1
2014 Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ivers N, Butt D, Jaakkimainen RL, Gunraj N, Ahluwalia V, Bombardier C. Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system. Bmj Open. 4: e003888. PMID 24486677 DOI: 10.1136/bmjopen-2013-003888  1
2014 Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest. 146: 563-72. PMID 24384637 DOI: 10.1378/chest.13-2058  1
2014 Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, Fautrel B, Bosworth A, Cifaldi M, Gignac MA, Hofstetter C, Leong A, Montie P, Petersson IF, Purcaru O, ... Bombardier C, et al. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research. The Journal of Rheumatology. 41: 165-76. PMID 24128774 DOI: 10.3899/jrheum.130815  1
2014 Sivera F, Andrés M, Carmona L, Kydd AS, Moi J, Seth R, Sriranganathan M, van Durme C, van Echteld I, Vinik O, Wechalekar MD, Aletaha D, Bombardier C, Buchbinder R, Edwards CJ, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Annals of the Rheumatic Diseases. 73: 328-35. PMID 23868909 DOI: 10.1136/annrheumdis-2013-203325  1
2013 Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ahluwalia V, Ivers N, Butt D, Jaakkimainen RL, Tomlinson G, Bombardier C. The rising burden of rheumatoid arthritis surpasses rheumatology supply in Ontario. Canadian Journal of Public Health = Revue Canadienne De Santé Publique. 104: e450-5. PMID 24495819 DOI: 10.17269/cjph.104.4115  1
2013 Marin TJ, Furlan AD, Bombardier C, van Tulder M. Fifteen years of the cochrane back review group. Spine. 38: 2057-63. PMID 24220307 DOI: 10.1097/BRS.0000000000000006  1
2013 Hazlewood GS, Naimark D, Gardam M, Bykerk V, Bombardier C. Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis. Arthritis Care & Research. 65: 1722-31. PMID 23836530 DOI: 10.1002/acr.22063  1
2013 Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. The Cochrane Database of Systematic Reviews. 5: CD000951. PMID 23728635 DOI: 10.1002/14651858.CD000951.pub2  1
2013 Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 382: 769-79. PMID 23726390 DOI: 10.1016/S0140-6736(13)60900-9  1
2013 Widdifield J, Bernatsky S, Paterson JM, Tu K, Ng R, Thorne JC, Pope JE, Bombardier C. Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists. Arthritis Care & Research. 65: 1582-91. PMID 23592598 DOI: 10.1002/acr.22031  1
2013 Tang K, Beaton DE, Lacaille D, Gignac MA, Bombardier C. Sensibility of five at-work productivity measures was endorsed by patients with osteoarthritis or rheumatoid arthritis. Journal of Clinical Epidemiology. 66: 546-56. PMID 23466017 DOI: 10.1016/j.jclinepi.2012.12.009  1
2013 Widdifield J, Labrecque J, Lix L, Paterson JM, Bernatsky S, Tu K, Ivers N, Bombardier C. Systematic review and critical appraisal of validation studies to identify rheumatic diseases in health administrative databases. Arthritis Care & Research. 65: 1490-503. PMID 23436765 DOI: 10.1002/acr.21993  1
2013 Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Annals of Internal Medicine. 158: 280-6. PMID 23420236 DOI: 10.7326/0003-4819-158-4-201302190-00009  1
2013 Bombardier C, Mian S. Quality indicators in rheumatoid arthritis care: using measurement to promote quality improvement. Annals of the Rheumatic Diseases. 72: ii128-31. PMID 23253925 DOI: 10.1136/annrheumdis-2012-202259  1
2013 Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, Pope J, Cividino A, Bombardier C. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care & Research. 65: 353-61. PMID 22833532 DOI: 10.1002/acr.21812  1
2012 Adams K, Bombardier C, van der Heijde DM. Safety of pain therapy during pregnancy and lactation in patients with inflammatory arthritis: a systematic literature review. The Journal of Rheumatology. Supplement. 90: 59-61. PMID 22942331 DOI: 10.3899/jrheum.120344  1
2012 Adams K, Bombardier C, van der Heijde D. Safety and efficacy of on-demand versus continuous use of nonsteroidal antiinflammatory drugs in patients with inflammatory arthritis: a systematic literature review. The Journal of Rheumatology. Supplement. 90: 56-8. PMID 22942330 DOI: 10.3899/jrheum.120343  1
2012 Hazlewood G, van der Heijde DM, Bombardier C. Paracetamol for the management of pain in inflammatory arthritis: a systematic literature review. The Journal of Rheumatology. Supplement. 90: 11-6. PMID 22942323 DOI: 10.3899/jrheum.120336  1
2012 Englbrecht M, Tarner IH, van der Heijde DM, Manger B, Bombardier C, Müller-Ladner U. Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review. The Journal of Rheumatology. Supplement. 90: 3-10. PMID 22942322 DOI: 10.3899/jrheum.120335  1
2012 Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, ... ... Bombardier C, et al. Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort. The Journal of Rheumatology. 39: 2088-97. PMID 22896027 DOI: 10.3899/jrheum.120100  1
2012 Gagnier JJ, Moher D, Boon H, Beyene J, Bombardier C. Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature. Bmc Medical Research Methodology. 12: 111. PMID 22846171 DOI: 10.1186/1471-2288-12-111  1
2012 Bombardier C, Hazlewood GS, Akhavan P, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, et al. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. The Journal of Rheumatology. 39: 1583-602. PMID 22707613 DOI: 10.3899/jrheum.120165  1
2012 Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, Felson DT, Hajjaj-Hassouni N, Hochberg M, Logeart I, Matucci-Cerinic M, Van De Laar M, Van Der Heijde D, Dougados M. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study Arthritis Care and Research. 64: 1699-1707. PMID 22674853 DOI: 10.1002/acr.21747  1
2012 Gagnier JJ, Moher D, Boon H, Bombardier C, Beyene J. An empirical study using permutation-based resampling in meta-regression. Systematic Reviews. 1: 18. PMID 22587815 DOI: 10.1186/2046-4053-1-18  1
2012 Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care & Research. 64: 625-39. PMID 22473917 DOI: 10.1002/acr.21641  1
2012 Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, Hazlewood G, Marks JL, Radner H, Ramiro S, Richards BL, Tarner IH, Aletaha D, Bombardier C, Landewé RB, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford, England). 51: 1416-25. PMID 22447886 DOI: 10.1093/rheumatology/kes032  1
2012 Bombardier C, Barbieri M, Parthan A, Zack DJ, Walker V, Macarios D, Smolen JS. The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review. Annals of the Rheumatic Diseases. 71: 836-44. PMID 22128079 DOI: 10.1136/annrheumdis-2011-200343  1
2012 Bykerk VP, Schieir O, Akhavan P, Hazlewood GS, Cheng CK, Bombardier C. Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations. The Journal of Rheumatology. 39: 1555-8. PMID 21885494 DOI: 10.3899/jrheum.110208  1
2011 Tang K, Beaton DE, Boonen A, Gignac MA, Bombardier C. Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS-RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Questionnaire (WPAI). Arthritis Care & Research. 63: S337-49. PMID 22588755 DOI: 10.1002/acr.20633  1
2011 Bombardier C, Laine L, Day R, Hawkey CJ, Hochberg MC, Schnitzer TJ. Rofecoxib and clinically significant gastrointestinal events. The American Journal of the Medical Sciences. 342: 438-9. PMID 22030845 DOI: 10.1097/MAJ.0b013e31822f3ff4  1
2011 Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, ... ... Bombardier C, et al. Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort. The Journal of Rheumatology. 38: 2342-5. PMID 21885485 DOI: 10.3899/jrheum.110249  1
2011 Tang K, Escorpizo R, Beaton DE, Bombardier C, Lacaille D, Zhang W, Anis AH, Boonen A, Verstappen SM, Buchbinder R, Osborne RH, Fautrel B, Gignac MA, Tugwell PS. Measuring the impact of arthritis on worker productivity: perspectives, methodologic issues, and contextual factors. The Journal of Rheumatology. 38: 1776-90. PMID 21807801 DOI: 10.3899/jrheum.110405  1
2011 Jamal S, Alibhai SM, Badley EM, Bombardier C. Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. The Journal of Rheumatology. 38: 1282-8. PMID 21572157 DOI: 10.3899/jrheum.101315  1
2011 Gladman DD, Bombardier C, Thorne C, Haraoui B, Khraishi M, Rahman P, Bensen W, Syrotuik J, Poulin-Costello M. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial. The Journal of Rheumatology. 38: 1355-62. PMID 21572156 DOI: 10.3899/jrheum.100698  1
2011 Tang K, Beaton DE, Gignac MA, Bombardier C. Rasch analysis informed modifications to the Work Instability Scale for Rheumatoid Arthritis for use in work-related upper limb disorders. Journal of Clinical Epidemiology. 64: 1242-51. PMID 21530170 DOI: 10.1016/j.jclinepi.2011.02.002  1
2011 Hazlewood G, Aletaha D, Carmona L, Landewé RB, van der Heijde DM, Bijlsma JW, Bykerk VP, Canhão H, Catrina AI, Durez P, Edwards CJ, Leeb BF, Mjaavatten MD, Martinez-Osuna P, Montecucco C, ... ... Bombardier C, et al. Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. The Journal of Rheumatology. Supplement. 87: 54-8. PMID 21364058 DOI: 10.3899/jrheum.101076  1
2011 Castrejón I, Silva-Fernández L, Bombardier C, Carmona L. Clinical composite measures of disease activity for diagnosis and followup of undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 48-53. PMID 21364057 DOI: 10.3899/jrheum.101075  1
2011 Thevissen K, Vercoutere W, Bombardier C, Landewé RB. Diagnostic and prognostic value of synovial biopsy in adult undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 45-7. PMID 21364056 DOI: 10.3899/jrheum.101074  1
2011 Silva-Fernández L, Castrejón I, Bombardier C, Carmona L. Diagnostic and prognostic value of genetics in undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 38-44. PMID 21364055 DOI: 10.3899/jrheum.101073  1
2011 Machado PM, Koevoets R, Bombardier C, van der Heijde DM. The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 31-7. PMID 21364054 DOI: 10.3899/jrheum.101072  1
2011 Koevoets R, Machado P, Bombardier C, van der Heijde DM. The value of conventional radiographs in undifferentiated arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 26-30. PMID 21364053 DOI: 10.3899/jrheum.101071  1
2011 Schoels M, Bombardier C, Aletaha D. Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 20-5. PMID 21364052 DOI: 10.3899/jrheum.101070  1
2011 Vercoutere W, Thevissen K, Bombardier C, Landewé RB. Diagnostic and predictive value of acute-phase reactants in adult undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 15-9. PMID 21364051 DOI: 10.3899/jrheum.101069  1
2011 Kuriya B, Villeneuve E, Bombardier C. Diagnostic and prognostic value of history-taking and physical examination in undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 10-4. PMID 21364050 DOI: 10.3899/jrheum.101098  1
2011 Villeneuve E, Kuriya B, Bombardier C. Patients considered as having undifferentiated peripheral inflammatory arthritis: a systematic review. The Journal of Rheumatology. Supplement. 87: 3-9. PMID 21364049 DOI: 10.3899/jrheum.101068  1
2011 Bombardier C, van der Heijde DM. How to investigate and follow up undifferentiated peripheral inflammatory arthritis? 3e initiative 2008-2009: systematic reviews and clinical algorithm. The Journal of Rheumatology. Supplement. 87: 1-2. PMID 21364048 DOI: 10.3899/jrheum.101067  1
2011 Gagnier JJ, Moher D, Boon H, Beyene J, Bombardier C. Randomized controlled trials of herbal interventions underreport important details of the intervention Journal of Clinical Epidemiology. 64: 760-769. PMID 21208777 DOI: 10.1016/j.jclinepi.2010.10.005  1
2011 Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Seminars in Arthritis and Rheumatism. 41: 81-9. PMID 21168187 DOI: 10.1016/j.semarthrit.2010.09.004  1
2011 Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis. Annals of the Rheumatic Diseases. 70: 266-71. PMID 21097801 DOI: 10.1136/ard.2010.132134  1
2011 Bombardier C, Evans CJ, Katz N, Mardekian J, Zlateva G, Simon LS. Further qualification of a therapeutic responder index for patients with chronic low back pain. The Journal of Rheumatology. 38: 362-9. PMID 21041275 DOI: 10.3899/jrheum.091444  1
2011 Katchamart W, Faulkner A, Feldman B, Tomlinson G, Bombardier C. PubMed had a higher sensitivity than Ovid-MEDLINE in the search for systematic reviews. Journal of Clinical Epidemiology. 64: 805-7. PMID 20926257 DOI: 10.1016/j.jclinepi.2010.06.004  1
2011 Borkhoff CM, Wieland ML, Myasoedova E, Ahmad Z, Welch V, Hawker GA, Li LC, Buchbinder R, Ueffing E, Beaton D, Cardiel MH, Gabriel SE, Guillemin F, Adebajo AO, Bombardier C, et al. Reaching those most in need: a scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis. Arthritis Care & Research. 63: 39-52. PMID 20842715 DOI: 10.1002/acr.20349  1
2011 Widdifield J, Bernatsky S, Paterson JM, Thorne JC, Cividino A, Pope J, Gunraj N, Bombardier C. Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective. Arthritis Care & Research. 63: 53-7. PMID 20806274 DOI: 10.1002/acr.20304  1
2011 Van Der Velde G, Pham B, MacHado M, Ieraci L, Witteman W, Bombardier C, Krahn M. Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review Arthritis Care and Research. 63: 65-78. PMID 20740606 DOI: 10.1002/acr.20338  1
2011 Machado P, Castrejon I, Katchamart W, Koevoets R, Kuriya B, Schoels M, Silva-Fernández L, Thevissen K, Vercoutere W, Villeneuve E, Aletaha D, Carmona L, Landewé R, van der Heijde D, Bijlsma JW, ... ... Bombardier C, et al. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Annals of the Rheumatic Diseases. 70: 15-24. PMID 20724311 DOI: 10.1136/ard.2010.130625  1
2011 Gossec L, Bijlsma JW, Bombardier C, Canhão H, Devlin J, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Ostergaard M, Pereira IA, Ramos-Remus C, et al. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists. Annals of the Rheumatic Diseases. 70: 388-9. PMID 20472594 DOI: 10.1136/ard.2010.128652  1
2011 Dionne CE, Le Sage N, Franche RL, Dorval M, Bombardier C, Deyo RA. Five questions predicted long-term, severe, back-related functional limitations: evidence from three large prospective studies. Journal of Clinical Epidemiology. 64: 54-66. PMID 20452744 DOI: 10.1016/j.jclinepi.2010.02.004  1
2010 Pease C, Pope JE, Thorne C, Haraoui BP, Truong D, Bombardier C, Widdifield J, Psaradellis E, Sampalis JS, Bonner A. Canadian variation by province in rheumatoid arthritis initiating anti-tumor necrosis factor therapy: results from the optimization of adalimumab trial. The Journal of Rheumatology. 37: 2469-74. PMID 20843910 DOI: 10.3899/jrheum.091447  1
2010 Tang K, Beaton DE, Gignac MA, Lacaille D, Zhang W, Bombardier C. The Work Instability Scale for rheumatoid arthritis predicts arthritis-related work transitions within 12 months. Arthritis Care & Research. 62: 1578-87. PMID 20521332 DOI: 10.1002/acr.20272  1
2010 Katchamart W, Bourré-Tessier J, Donka T, Drouin J, Rohekar G, Bykerk VP, Haraoui B, LeClerq S, Mosher DP, Pope JE, Shojania K, Thomson J, Thorne JC, Bombardier C, Blocka K, et al. Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis Journal of Rheumatology. 37: 1422-1430. PMID 20516029 DOI: 10.3899/jrheum.090978  1
2010 Katchamart W, Bombardier C. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis. The Journal of Rheumatology. 37: 1411-5. PMID 20436069 DOI: 10.3899/jrheum.090980  1
2010 Tang K, Beaton DE, Lacaille D, Gignac MA, Zhang W, Anis AH, Bombardier C. The Work Instability Scale for Rheumatoid Arthritis (RA-WIS): Does it work in osteoarthritis? Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 19: 1057-68. PMID 20419502 DOI: 10.1007/s11136-010-9656-y  1
2010 Katchamart W, Trudeau J, Phumethum V, Bombardier C. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis. The Cochrane Database of Systematic Reviews. CD008495. PMID 20393970 DOI: 10.1002/14651858.CD008495  1
2010 Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C. Predictors for remission in rheumatoid arthritis patients: A systematic review. Arthritis Care & Research. 62: 1128-43. PMID 20235210 DOI: 10.1002/acr.20188  1
2010 Beaton DE, Tang K, Gignac MA, Lacaille D, Badley EM, Anis AH, Bombardier C. Reliability, validity, and responsiveness of five at-work productivity measures in patients with rheumatoid arthritis or osteoarthritis. Arthritis Care & Research. 62: 28-37. PMID 20191488 DOI: 10.1002/acr.20011  1
2010 Salliot C, Bombardier C, Saraux A, Combe B, Dougados M. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort. Annals of the Rheumatic Diseases. 69: 1683-6. PMID 19740903 DOI: 10.1136/ard.2009.111179  1
2009 Simon LS, Strand CV, Boers M, Brooks PM, Tugwell PS, Bombardier C, Fries JF, Henry D, Goldkind L, Guyatt G, Laupacis A, Lynd L, Macdonald T, Mamdani M, Moore A, et al. How to ascertain drug safety in the context of benefit. Controversies and concerns. The Journal of Rheumatology. 36: 2114-21. PMID 19738223 DOI: 10.3899/jrheum.090591  1
2009 Beaton D, Bombardier C, Escorpizo R, Zhang W, Lacaille D, Boonen A, Osborne RH, Anis AH, Strand CV, Tugwell PS. Measuring worker productivity: frameworks and measures. The Journal of Rheumatology. 36: 2100-9. PMID 19738221 DOI: 10.3899/jrheum.090366  1
2009 Furlan AD, Pennick V, Bombardier C, van Tulder M. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine. 34: 1929-41. PMID 19680101 DOI: 10.1097/BRS.0b013e3181b1c99f  1
2009 Bernatsky S, Paterson M, Thorne C, Cividino A, Pope J, Hux J, Bombardier C. Potential effects of a national consensus statement on optimal treatment of early rheumatoid arthritis in Ontario Scandinavian Journal of Rheumatology. 38: 390-391. PMID 19579090 DOI: 10.1080/03009740902842190  1
2009 Ammendolia C, Côté P, Hogg-Johnson S, Bombardier C. Utilization and costs of lumbar and full spine radiography by Ontario chiropractors from 1994 to 2001. The Spine Journal : Official Journal of the North American Spine Society. 9: 556-63. PMID 19447076 DOI: 10.1016/j.spinee.2009.03.009  1
2009 van der Velde G, Hogg-Johnson S, Bayoumi AM, Cassidy JD, Côté P, Boyle E, Llewellyn-Thomas H, Chan S, Subrata P, Hoving JL, Hurwitz E, Bombardier C, Krahn M. Identifying the best treatment among common nonsurgical neck pain treatments: a decision analysis. Journal of Manipulative and Physiological Therapeutics. 32: S209-18. PMID 19251067 DOI: 10.1016/j.jmpt.2008.11.021  1
2009 Hayden JA, Chou R, Hogg-Johnson S, Bombardier C. Systematic reviews of low back pain prognosis had variable methods and results-guidance for future prognosis reviews Journal of Clinical Epidemiology. 62. PMID 19136234 DOI: 10.1016/j.jclinepi.2008.09.004  1
2009 Katchamart W, Trudeau J, Phumethum V, Bombardier C. Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: A systematic review and meta-analysis Annals of the Rheumatic Diseases. 68: 1105-1112. PMID 19054823 DOI: 10.1136/ard.2008.099861  1
2009 Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Annals of the Rheumatic Diseases. 68: 1086-93. PMID 19033291 DOI: 10.1136/ard.2008.094474  1
2008 Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis and Rheumatism. 59: 1371-7. PMID 18821648 DOI: 10.1002/art.24123  1
2008 Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Annals of the Rheumatic Diseases. 67: 1360-4. PMID 18791055 DOI: 10.1136/ard.2008.091454  1
2008 Ammendolia C, Taylor JA, Pennick V, Côté P, Hogg-Johnson S, Bombardier C. Adherence to radiography guidelines for low back pain: a survey of chiropractic schools worldwide. Journal of Manipulative and Physiological Therapeutics. 31: 412-8. PMID 18722195 DOI: 10.1016/j.jmpt.2008.06.010  1
2008 Li LC, Badley EM, MacKay C, Mosher D, Jamal SW, Jones A, Bombardier C. An evidence-informed, integrated framework for rheumatoid arthritis care. Arthritis and Rheumatism. 59: 1171-83. PMID 18668611 DOI: 10.1002/art.23931  1
2008 Hayden JA, Côté P, Steenstra IA, Bombardier C. Identifying phases of investigation helps planning, appraising, and applying the results of explanatory prognosis studies Journal of Clinical Epidemiology. 61: 552-560. PMID 18471659 DOI: 10.1016/j.jclinepi.2007.08.005  1
2008 Furlan AD, Tomlinson G, Jadad AA, Bombardier C. Examining heterogeneity in meta-analysis: comparing results of randomized trials and nonrandomized studies of interventions for low back pain. Spine. 33: 339-48. PMID 18303468 DOI: 10.1097/BRS.0b013e31816233b5  1
2008 Furlan AD, Tomlinson G, Jadad AA, Bombardier C. Methodological quality and homogeneity influenced agreement between randomized trials and nonrandomized studies of the same intervention for back pain. Journal of Clinical Epidemiology. 61: 209-31. PMID 18226744 DOI: 10.1016/j.jclinepi.2007.04.019  1
2008 van der Velde G, Hogg-Johnson S, Bayoumi AM, Cassidy JD, Côté P, Boyle E, Llewellyn-Thomas H, Chan S, Subrata P, Hoving JL, Hurwitz E, Bombardier C, Krahn M. Identifying the best treatment among common nonsurgical neck pain treatments: a decision analysis. Spine. 33: S184-91. PMID 18204391 DOI: 10.1097/BRS.0b013e31816454f8  1
2007 Ammendolia C, Côté P, Hogg-Johnson S, Bombardier C. Do chiropractors adhere to guidelines for back radiographs? A study of chiropractic teaching clinics in Canada. Spine. 32: 2509-14. PMID 18090093 DOI: 10.1097/BRS.0b013e3181578dee  0.52
2007 Michaud K, Bombardier C, Emery P. Quality of life in patients with rheumatoid arthritis: Does abatacept make a difference? Clinical and Experimental Rheumatology. 25. PMID 17977487  1
2007 Beresniak A, Russell AS, Haraoui B, Bessette L, Bombardier C, Duru G. Advantages and limitations of utility assessment methods in rheumatoid arthritis. The Journal of Rheumatology. 34: 2193-200. PMID 17937471  1
2007 Guzmán J, Esmail R, Karjalainen K, Malmivaara A, Irvin E, Bombardier C. WITHDRAWN: Multidisciplinary bio-psycho-social rehabilitation for chronic low-back pain Cochrane Database of Systematic Reviews (Online). PMID 17636646  1
2007 Keller A, Hayden J, Bombardier C, Van Tulder M. Effect sizes of non-surgical treatments of non-specific low-back pain European Spine Journal. 16: 1776-1788. PMID 17619914 DOI: 10.1007/s00586-007-0379-x  1
2007 Simon LS, Evans C, Katz N, Bombardier C, West C, Robbins J, Copley-Merriman C, Markman J, Coombs JH. Preliminary development of a responder index for chronic low back pain. The Journal of Rheumatology. 34: 1386-91. PMID 17552065  1
2007 Escorpizo R, Bombardier C, Boonen A, Hazes JM, Lacaille D, Strand V, Beaton D. Worker productivity outcome measures in arthritis. The Journal of Rheumatology. 34: 1372-80. PMID 17552063  0.48
2007 Côté P, Hogg-Johnson S, Cassidy JD, Carroll L, Frank JW, Bombardier C. Early aggressive care and delayed recovery from whiplash: isolated finding or reproducible result? Arthritis and Rheumatism. 57: 861-8. PMID 17530688 DOI: 10.1002/art.22775  0.52
2007 Tubach F, Ravaud P, Beaton D, Boers M, Bombardier C, Felson DT, van der Heijde D, Wells G, Dougados M. Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. The Journal of Rheumatology. 34: 1188-93. PMID 17477485  0.4
2007 Beaton DE, Bombardier C, Cole DC, Hogg-Johnson S, Van Eerd D, Amadio PC, Buchbinder R, Carette S, Evanoff BA, Kennedy C, Novak CB, Pransky G, Viikari-Juntura E. A pattern recognition approach to the development of a classification system for upper-limb musculoskeletal disorders of workers Scandinavian Journal of Work, Environment and Health. 33: 131-139. PMID 17460801  1
2006 Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin AS, Bombardier C, Weinblatt ME, van der Heijde D, Erdmann E, Laine L. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet. 368: 1771-81. PMID 17113426 DOI: 10.1016/S0140-6736(06)69666-9  1
2006 Vliet Vlieland TP, Li LC, MacKay C, Bombardier C, Badley EM. Current topics on models of care in the management of inflammatory arthritis. The Journal of Rheumatology. 33: 1900-3. PMID 16960952  0.4
2006 Li LC, Bombardier C. Setting priorities in arthritis care: Care III Conference. The Journal of Rheumatology. 33: 1891-4. PMID 16960949  0.4
2006 Li LC, Maetzel A, Davis AM, Lineker SC, Bombardier C, Coyte PC. Primary therapist model for patients referred for rheumatoid arthritis rehabilitation: a cost-effectiveness analysis. Arthritis and Rheumatism. 55: 402-10. PMID 16739183 DOI: 10.1002/art.21989  1
2006 Bombardier C, Laine L, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ, Weaver A. Response to expression of concern regarding VIGOR study. The New England Journal of Medicine. 354: 1196-9. PMID 16495387 DOI: 10.1056/NEJMc066096  0.56
2006 Li LC, Davis AM, Lineker SC, Coyte PC, Bombardier C. Effectiveness of the primary therapist model for rheumatoid arthritis rehabilitation: a randomized controlled trial. Arthritis and Rheumatism. 55: 42-52. PMID 16463410 DOI: 10.1002/art.21692  0.4
2006 Tannenbaum H, Bombardier C, Davis P, Russell AS. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference. The Journal of Rheumatology. 33: 140-57. PMID 16331802  1
2005 Côté P, Hogg-Johnson S, Cassidy JD, Carroll L, Frank JW, Bombardier C. Initial patterns of clinical care and recovery from whiplash injuries: a population-based cohort study. Archives of Internal Medicine. 165: 2257-63. PMID 16246992 DOI: 10.1001/archinte.165.19.2257  1
2005 Loisel P, Côté P, Durand MJ, Franche RL, Sullivan MJ, Baril R, Gagnon D, Lacroix A, Larivière C, Marchand S, Bombardier C, Cole D, Guzman J, Hogg-Johnson S, Arsenault B, et al. Training the next generation of researchers in work disability prevention: the Canadian Work Disability Prevention CIHR Strategic Training Program. Journal of Occupational Rehabilitation. 15: 273-84. PMID 16119220 DOI: 10.1007/s10926-005-5936-8  1
2005 Marshall JC, Vincent JL, Guyatt G, Angus DC, Abraham E, Bernard G, Bombardier C, Calandra T, Jørgensen HS, Sylvester R, Boers M. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Critical Care Medicine. 33: 1708-16. PMID 16096445 DOI: 10.1097/01.CCM.0000174478.70338.03  1
2004 Li LC, Maetzel A, Pencharz JN, Maguire L, Bombardier C. Use of mainstream nonpharmacologic treatment by patients with arthritis. Arthritis and Rheumatism. 51: 203-9. PMID 15077260 DOI: 10.1002/art.20244  1
2004 Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Annals of the Rheumatic Diseases. 63: 395-401. PMID 15020333 DOI: 10.1136/ard.2003.006031  1
2002 Maetzel A, Strand V, Tugwell P, Wells G, Bombardier C. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Arthritis and Rheumatism. 47: 655-61. PMID 12522841 DOI: 10.1002/art.10793  1
2002 Maetzel A, Strand V, Tugwell P, Wells G, Bombardier C. Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trial. Pharmacoeconomics. 20: 61-70. PMID 11817993 DOI: 10.2165/00019053-200220010-00006  1
2001 Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. Journal of Clinical Epidemiology. 54: 1204-17. PMID 11750189 DOI: 10.1016/S0895-4356(01)00407-3  1
2001 Beaton DE, Tarasuk V, Katz JN, Wright JG, Bombardier C. "Are you better?" A qualitative study of the meaning of recovery. Arthritis and Rheumatism. 45: 270-9. PMID 11409669 DOI: 10.1002/1529-0131(200106)45:3<270::AID-ART260>3.0.CO;2-T  1
2001 Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists. 14: 128-46. PMID 11382253  1
2001 Gabriel S, Drummond M, Suarez-Almazor ME, Ruff B, Guillemin F, Bombardier C, Boers M, Maetzel A, Ruof J, Cranney A, Marentette M, Tugwell P. OMERACT 5 Economics Working Group: summary, recommendations, and research agenda. The Journal of Rheumatology. 28: 670-3. PMID 11296980  1
2001 Bombardier C, Hayden J, Beaton DE. Minimal clinically important difference. Low back pain: outcome measures. The Journal of Rheumatology. 28: 431-8. PMID 11246692  1
2001 Beaton DE, Bombardier C, Katz JN, Wright JG, Wells G, Boers M, Strand V, Shea B. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. The Journal of Rheumatology. 28: 400-5. PMID 11246687  1
2000 Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 25: 3186-91. PMID 11124735 DOI: 10.1097/00007632-200012150-00014  1
2000 Maetzel A, Wong A, Strand V, Tugwell P, Wells G, Bombardier C. Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology (Oxford, England). 39: 975-81. PMID 10986302  1
2000 Maetzel A, Johnson SH, Woodbury M, Bombardier C. Use of grade membership analysis to profile the practice styles of individual physicians in the management of acute low back pain. Journal of Clinical Epidemiology. 53: 195-205. PMID 10729692 DOI: 10.1016/S0895-4356(99)00120-1  1
2000 Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A, Tindall E, Offenberg H, Poiley J, Rutstein J, Dietz F, Brodsky A, Harris R, et al. Clinical improvement as reflected in measures of function and health- related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial Arthritis and Rheumatism. 43: 506-514. PMID 10728742 DOI: 10.1002/1529-0131(200003)43:3<506::AID-ANR5>3.0.CO;2-U  1
1999 Davis AM, Beaton DE, Hudak P, Amadio P, Bombardier C, Cole D, Hawker G, Katz JN, Makela M, Marx RG, Punnett L, Wright JG. Measuring disability of the upper extremity: a rationale supporting the use of a regional outcome measure. Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists. 12: 269-74. PMID 10622192  1
1999 Bombardier C, Maetzel A. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies? Annals of the Rheumatic Diseases. 58: I82-5. PMID 10577979  1
1999 Maetzel A, Bombardier C. Give observational studies a chance: better observational studies make better economic evaluations. The Journal of Rheumatology. 26: 2298-9. PMID 10555880  1
1999 Strand V, Tugwell P, Bombardier C, Maetzel A, Crawford B, Dorrier C, Thompson A, Wells G. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis and Rheumatism. 42: 1870-8. PMID 10513801 DOI: 10.1002/1529-0131(199909)42:9<1870::AID-ANR11>3.0.CO;2-D  1
1998 Maetzel A, Bombardier C, Strand V, Tugwell P, Wells G. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey. The Journal of Rheumatology. 25: 2331-8. PMID 9858426  1
1998 Maetzel A, Ferraz MB, Bombardier C. A review of cost-effectiveness analyses in rheumatology and related disciplines. Current Opinion in Rheumatology. 10: 136-40. PMID 9567209 DOI: 10.1097/00002281-199803000-00009  1
1998 Maetzel A, Ferraz MB, Bombardier C. The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs. Arthritis and Rheumatism. 41: 16-25. PMID 9433865 DOI: 10.1002/1529-0131(199801)41:1<16::AID-ART3>3.0.CO;2-4  1
1997 Ferraz MB, Maetzel A, Bombardier C. A summary of economic evaluations published in the field of rheumatology and related disciplines. Arthritis and Rheumatism. 40: 1587-93. PMID 9324012 DOI: 10.1002/1529-0131(199709)40:9<1587::AID-ART7>3.0.CO;2-C  1
1997 Maetzel A, Mäkelä M, Hawker G, Bombardier C. Osteoarthritis of the hip and knee and mechanical occupational exposure--a systematic overview of the evidence. The Journal of Rheumatology. 24: 1599-607. PMID 9263158  1
1997 Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. Journal of Clinical Epidemiology. 50: 79-93. PMID 9048693 DOI: 10.1016/S0895-4356(96)00296-X  1
1996 Beaton DE, Bombardier C, Hogg-Johnson SA. Measuring health in injured workers: a cross-sectional comparison of five generic health status instruments in workers with musculoskeletal injuries. American Journal of Industrial Medicine. 29: 618-31. PMID 8773722 DOI: 10.1002/(SICI)1097-0274(199606)29:6<618::AID-AJIM6>3.0.CO;2-F  1
Show low-probability matches.